# Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis

> **NCT02595073** · PHASE3 · COMPLETED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 124 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** DSXS
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02595073
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-04
- **Primary completion:** 2017-01-17
- **Final completion:** 2017-08-29
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2018-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02595073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02595073, "Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT02595073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*